Experienced in Oculopharyngeal Muscular Dystrophy

Manuela Contin

Bologna, IT 
Experienced in Oculopharyngeal Muscular Dystrophy
Bologna, IT 
OverviewLocationsClinical Research

Overview

Manuela Contin practices in Bologna, Italy. Ms. Contin is rated as an Experienced expert by MediFind in the treatment of Oculopharyngeal Muscular Dystrophy. Her top areas of expertise are Mitochondrial Neurogastrointestinal Encephalopathy Disease, Myoclonic Epilepsy, MELAS Syndrome, and Parkinson's Disease.

Her clinical research consists of co-authoring 53 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Oculopharyngeal Muscular Dystrophy.

Gender
Female

Locations

Bologna, Italy
Other Locations
Cesena, Italy
Milan, Italy
Bellaria, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Biological, Device
Study Phase: Phase 3
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Biological, Device
Study Phase: Phase 3
View 1 Less Clinical Trial

53 Total Publications

Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failure.
Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failure.
Journal: Autonomic neuroscience : basic & clinical
Published: March 13, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Contin's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile